Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT06179693
Eligibility Criteria:
Inclusion Criteria:
* Established lymphoma (non-Hodgkin's lymphoma and Hodgkin's disease) being staged;
* Performing the PET/CT examination within two weeks of diagnosis and before treatment;
* Signing of the Informed Consent.
Exclusion Criteria:
* patients \<18 years;
* Patients who have not signed the Informed Consent;
* Execution of previous anti-inflammatory or anti-inflammatory therapies in the 4 weeks preceding the PET exam.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06179693
Study Brief:
Protocol Section:
NCT06179693